T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+6.61%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$868B
AUM Growth
+$32.7B
Cap. Flow
-$5.38B
Cap. Flow %
-0.62%
Top 10 Hldgs %
33.84%
Holding
3,060
New
81
Increased
1,782
Reduced
864
Closed
51

Sector Composition

1 Technology 32.36%
2 Healthcare 15.15%
3 Financials 10.54%
4 Consumer Discretionary 10.47%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WTI icon
2876
W&T Offshore
WTI
$261M
$69K ﹤0.01%
32,053
+2,644
+9% +$5.69K
PROK icon
2877
ProKidney
PROK
$296M
$68K ﹤0.01%
35,405
+16,211
+84% +$31.1K
BMTX
2878
DELISTED
BM Technologies, Inc.
BMTX
$68K ﹤0.01%
19,800
VXRT
2879
DELISTED
Vaxart
VXRT
$67K ﹤0.01%
78,500
GRTS
2880
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$67K ﹤0.01%
114,100
+51,400
+82% +$30.2K
PRPL icon
2881
Purple Innovation
PRPL
$113M
$66K ﹤0.01%
66,646
+6,637
+11% +$6.57K
CMPX icon
2882
Compass Therapeutics
CMPX
$597M
$66K ﹤0.01%
35,616
+7,504
+27% +$13.9K
KZR icon
2883
Kezar Life Sciences
KZR
$29.2M
$65K ﹤0.01%
8,360
TEAD
2884
Teads Holding Co. Common Stock
TEAD
$153M
$65K ﹤0.01%
13,350
MCRB icon
2885
Seres Therapeutics
MCRB
$158M
$64K ﹤0.01%
3,370
-10,000
-75% -$190K
TRVI icon
2886
Trevi Therapeutics
TRVI
$992M
$64K ﹤0.01%
19,047
PSTX
2887
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$64K ﹤0.01%
22,186
+715
+3% +$2.06K
CCLD icon
2888
CareCloud
CCLD
$144M
$63K ﹤0.01%
23,700
FGEN icon
2889
FibroGen
FGEN
$46.5M
$63K ﹤0.01%
6,260
+2,544
+68% +$25.6K
ZURA icon
2890
Zura Bio
ZURA
$138M
$63K ﹤0.01%
+15,324
New +$63K
ATOS icon
2891
Atossa Therapeutics
ATOS
$105M
$62K ﹤0.01%
40,770
BRCC icon
2892
BRC Inc
BRCC
$183M
$62K ﹤0.01%
17,869
TCRX icon
2893
TScan Therapeutics
TCRX
$104M
$62K ﹤0.01%
12,301
CTV
2894
DELISTED
Innovid Corp.
CTV
$62K ﹤0.01%
34,211
SRTA
2895
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$322M
$60K ﹤0.01%
20,288
+911
+5% +$2.69K
FARM icon
2896
Farmer Brothers
FARM
$42.5M
$59K ﹤0.01%
29,600
LFMD icon
2897
LifeMD
LFMD
$288M
$59K ﹤0.01%
11,117
FRGE icon
2898
Forge Global Holdings
FRGE
$242M
$58K ﹤0.01%
2,902
+656
+29% +$13.1K
PYXS icon
2899
Pyxis Oncology
PYXS
$113M
$58K ﹤0.01%
15,720
TOON icon
2900
Kartoon Studios
TOON
$38.4M
$58K ﹤0.01%
66,240